CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade DiaMedica Therapeutics Inc. - DMAC CFD

3.6220
1.9%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0260
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 3.692
Open 3.612
1-Year Change 14.29%
Day's Range 3.562 - 3.722
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 3.6820 0.1600 4.54% 3.5220 3.7620 3.4520
Jul 24, 2024 3.6020 0.1900 5.57% 3.4120 3.7920 3.3920
Jul 23, 2024 3.4220 0.1000 3.01% 3.3220 3.4620 3.2620
Jul 22, 2024 3.4320 0.1700 5.21% 3.2620 3.5220 3.2420
Jul 19, 2024 3.2320 0.0000 0.00% 3.2320 3.3220 3.2320
Jul 18, 2024 3.2520 -0.1400 -4.13% 3.3920 3.4320 3.2320
Jul 17, 2024 3.4420 0.2000 6.17% 3.2420 3.5020 3.2420
Jul 16, 2024 3.3820 -0.0500 -1.46% 3.4320 3.5620 3.3620
Jul 15, 2024 3.5320 0.1400 4.13% 3.3920 3.7120 3.2920
Jul 12, 2024 3.4120 0.2200 6.89% 3.1920 3.4620 3.0420
Jul 11, 2024 3.1920 0.3600 12.71% 2.8320 3.2120 2.7720
Jul 10, 2024 2.9920 0.1300 4.54% 2.8620 3.0520 2.8620
Jul 9, 2024 2.9920 0.0200 0.67% 2.9720 3.0920 2.9220
Jul 8, 2024 3.0820 0.1700 5.84% 2.9120 3.1220 2.8620
Jul 5, 2024 2.8620 0.0600 2.14% 2.8020 2.9320 2.8020
Jul 3, 2024 2.8720 0.1600 5.90% 2.7120 2.9220 2.7120
Jul 2, 2024 2.7920 -0.1600 -5.42% 2.9520 3.0220 2.7120
Jul 1, 2024 2.8920 0.1200 4.33% 2.7720 2.8920 2.5920
Jun 28, 2024 2.9120 0.0500 1.75% 2.8620 3.0520 2.7920
Jun 27, 2024 2.9820 0.0300 1.02% 2.9520 2.9820 2.7320

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DiaMedica Therapeutics Inc. Company profile

About DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for neurological and kidney diseases, such as acute ischemic stroke (AIS) and chronic kidney disease (CKD). The Company's lead product DM199 mimics the behavior of naturally occurring human KLK1 proteins to preserve and restore circulation to stroke-damaged tissue and improve overall kidney function. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. DM199 therapy has the potential to improve circulation and overall function of critical systems, as well as reduce inflammation and oxidative stress. The Company also has other product pipelines for IgA Nephropathy and African Americans with CKD.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DiaMedica Therapeutics Inc revenues was not reported. Net loss increased 11% to $13.6M. Higher net loss reflects General and administrative - Balancing increase of 23% to $3.8M (expense), Research and development - Balancing increase of 7% to $8.3M (expense), Governmental assistance research incen decrease from $205K (income) to $0K.

Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

People also watch

XRP/USD

0.61 Price
+1.640% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

67,928.50 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,281.07 Price
+4.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading